Adaptive Biotechnologies Corp. (ADPT)
16.22
-0.20
(-1.19%)
USD |
NASDAQ |
Dec 31, 16:00
16.00
-0.22
(-1.39%)
After-Hours: 20:00
Adaptive Biotechnologies Market Cap: 2.477B for Dec. 31, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Regeneron Pharmaceuticals, Inc. | 81.13B |
| Zymeworks, Inc. | 1.987B |
| Cue Biopharma, Inc. | 24.41M |
| Recursion Pharmaceuticals, Inc. | 2.126B |
| Arcellx, Inc. | 3.775B |
Market Cap Related Metrics
| PS Ratio | 9.823 |
| Price to Book Value | 12.12 |
| Price | 16.22 |
| Earnings Yield | -3.32% |